CAChristina Kaijser Alin

Christina Kaijser Alin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Christina Kaijser Alin has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    More than just Bones – A qualitative study exploring the experiences and perceptions of women in the BONEMORE physical exercise trial

    by Peter W.S. Lindberg, Kristin Moystad Michelet, Christina Kaijser Alin, Eva Toth-Pal, Helena Salminen

    Physical exercise is one of the most effective non-pharmaceutical strategy for fracture prevention [1] and is strongly recommended by international guidelines for the management of osteoporosis [2,...

  • Open Access

    Effects of OsteoStrong vs. dynamic multicomponent exercise on physical function in older women in the BONEMORE randomized controlled trial

    by Peter W.S. Lindberg, Hans Ranch Lundin, Eva Andersson, Ann-Charlotte Grahn Kronhed, Eva Toth-Pal, Maria Sääf, Christina Kaijser Alin, Helena Salminen

    Background: Limited research exists on the effects of OsteoStrong on physical function in older women. Aim: This randomized controlled trial aimed to evaluate and compare the effects of OsteoStrong (OS) and dynamic multicomponent exercise (DME) on functional outcomes in older women with osteopenia or osteoporosis. Methods: A total of 194 women aged 65–79 years with a T-score of ≤–1.0 at the hip and/or spine were randomized to nine months of either OS (once weekly, 20 min) or DME (twice weekly, 60 min). Outcomes included measures of muscle strength (hand grip and back strength), back and trunk endurance, mobility (sit-to-stand tests, gait speed, Timed Up and Go), and balance (one-leg standing time, tandem standing, tandem walking). Measurements were conducted at baseline and again at nine months. Results: Both OS and DME showed significant improvements in grip strength, back strength, isometric trunk flexion endurance, gait speed 30 m (m/sec), 5 sit-to-stand (sec) and 50 sit-to-stand speed (n/sec) with no significant between-group differences. DME resulted in greater improvements in gait speed 30 m (+ 7.1% vs. +3.2%, p = 0.001), isometric trunk extension (+ 27.6% vs. +4.4%, p = 0.007), and one-leg standing balance (right leg: +13.1% vs. -2.1%, p = 0.001; left leg: +13.3% vs. -2.4%, p = 0.001) compared to OS. Conclusion: These findings suggest that while both OS and DME improve physical function in older women with osteopenia or osteoporosis, DME provides superior benefits in gait speed, back muscle endurance, and balance. These findings should be interpreted with caution, as they are based on secondary outcomes.


  • Open Access

    Correction: The effect of OsteoStrong compared to dynamic multicomponent exercise on bone strength in older women: the BONEMORE non-inferiority randomized controlled trial

    by Peter W. S. Lindberg, Kristin Moystad Michelet, Christina Kaijser Alin, Eva Andersson, Ann-Charlotte Grahn Kronhed, Per Magnusson, Sven Nyrén, Hans Ranch Lundin, Eva Toth-Pal, Maria Sääf, et al.

  • Open Access

    The effect of OsteoStrong compared to dynamic multicomponent exercise on bone strength in older women: the BONEMORE non-inferiority randomized controlled trial

    by Peter W. S. Lindberg, Kristin Moystad Michelet, Christina Kaijser Alin, Eva Andersson, Ann-Charlotte Grahn Kronhed, Per Magnusson, Sven Nyrén, Hans Ranch Lundin, Eva Toth-Pal, Maria Sääf, et al.

    Summary: The efficacy of OsteoStrong® (OS) on bone strength is limited, and how it compares to dynamic multicomponent exercise (DME) is unknown. In this randomized controlled trial, the effect of OS on bone material strength index (BMSi) in older women was non-inferior to that of DME. No significant interaction between treatment and time was observed in any measured outcomes, indicating no meaningful difference between the intervention groups. Although the OsteoStrong® intervention met the pre-specified non-inferiority margin compared to the DME group, the lack of efficacy of the DME intervention on BMSi limits the interpretation of this finding. Purpose: The aim of this study was to investigate whether the effect of using OS was non-inferior to DME for the primary outcome of BMSi in older women. Methods: Women aged 65–79 years with osteopenia or osteoporosis were randomized to 9 months of once-weekly OS (20 min) or twice-weekly DME (60 min/session). A total of 194 women (OS, 97; DME, 97), median age 70 years, participated in the trial. The primary outcome was BMSi measured with impact microindentation at the tibia. A pre-specified non-inferiority margin of BMSi −5.2 was applied to determine whether the intervention’s efficacy was not clinically worse than the comparator within an acceptable threshold. The secondary outcomes were bone mineral density (BMD) and bone markers (S-CTX, S-P1NP, S-BALP, and S-sclerostin). Results: At the 9-month follow-up, there were no significant differences between the groups in any of the outcomes. The mean between‑group difference in BMSi was 1.16, with a 95% confidence interval ranging from − 1.51 to 3.82. Since the lower limit of the confidence interval (− 1.51) did not cross the predefined non‑inferiority margin of − 5.2, non‑inferiority was established. There was a significant increase in BMSi by 2.9% in the OS group (from 73.9 ± 9.5 to 76 ± 9.4, p = 0.025), and lumbar spine BMD by 0.8% in the DME group (from 0.866 g/cm 2 ± 0.13 to 0.872 g/cm 2 ± 0.13, p = 0.016). Changes in femoral neck BMD were not significant. There were no significant within- or between-group differences in any of the bone markers at 3 and 9 months. Conclusions: Based on these findings, the effect of OsteoStrong® on BMSi in older women was non-inferior to that of dynamic multicomponent exercise. No significant interaction between treatment and time was observed in any measured outcomes, indicating no meaningful difference between the intervention groups. Although the OsteoStrong® intervention met the pre-specified non-inferiority margin compared to the DME group, the lack of efficacy of the DME intervention on BMSi limits the interpretation of this finding.